Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2 (4), 234-9

Thrombosis Associated With Viral Hepatitis


Thrombosis Associated With Viral Hepatitis

Luca Galli et al. J Clin Transl Hepatol.


Viral hepatitis may promote the development of venous thromboembolism (VTE) and, more specifically, portal vein thrombosis (PVT). In this narrative review, we summarize the clinical data and discuss the possible pathogenetic roles of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and hepatitis A, B, and C viruses (HAV, HBV, HCV) in the occurrence of VTE. CMV is the first qualified candidate to enter the list of VTE minor risk factors, and in the rare case of fulminant infection, both EBV and CMV, like any severe infection or inflammatory disease, increase risk for thrombosis. In chronic hepatitis B and C, it remains controversial whether antiphospholipid antibodies are important for thrombotic complications or merely an epiphenomenon. Retinal vein occlusion described in chronic hepatitis C is usually attributed to the treatment with interferon. Eltrombopag, used for HCV-related thrombocytopenia, has been associated with increased thrombotic risk. The imbalance between procoagulant and anticoagulant factors associated with chronic liver disease may have clinical implications. This may help to explain why these patients are not protected from clinical events such as VTE, PVT, and the progression of liver fibrosis.

Keywords: Cytomegalovirus; Epstein-Barr virus; Hepatitis; Hepatitis A, B and C virus; Thrombosis.

Conflict of interest statement

Conflict of interest: None

Similar articles

See all similar articles

Cited by 8 PubMed Central articles

See all "Cited by" articles


    1. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167–1173. 10.1016/S0140-6736(98)10266-0. - DOI - PubMed
    1. Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587–591. 10.1002/hep.510310307. - DOI - PubMed
    1. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367:1075–1079. 10.1016/S0140-6736(06)68474-2. - DOI - PubMed
    1. Levi M, Keller TT, van Gorp E, ten Cate H. Infection and inflammation and the coagulation system. Cardiovasc Res. 2003;60:26–39. 10.1016/S0008-6363(02)00857-X. - DOI - PubMed
    1. Squizzato A, Gerdes VEA, Büller HR. Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost. 2005;93:403–410. - DOI - PubMed